Product Reports Resources Pricing Login Book a demo

Standard Biotools

Biotech & Life Sciences · Boston, United States · Founded 1999 · IPO 2011

Biotech tools company that creates microfluidic-based chips and instrumentation for biological research

Revenue $83M
Power Law Thoroughbred$100M+ revenue

Talent graph

Standard Biotools's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 8 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

17 investors on Standard Biotools's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 17 investors entered at this stage
GE Equity
Smallcap World Fund
Alloy Ventures
EDBI
InterWest Partners
Versant Ventures
Lehman Brothers
Fidelity Contrafund
Wasatch Advisors
Caltech
California Institute of Technology
Invus
Bio*One Capital
Cross Creek
Lilly Ventures
EuclidSR Partners
Cross Creek Advisors

Standard Biotools mafia

Startups founded by Standard Biotools alumni

Former Standard Biotools employees who went on to start their own companies. Sorted by Dealroom signal score.

Intellia TherapeuticsEst. 2014
AMAndy MayUnited States
Signal score86
Carolina MolecularEst. 2025
John CorlissUnited States
Signal score68
IonpathEst. 2014
Harris FienbergUnited States
Signal score66
ProviviEst. 2013
Frances ArnoldUnited States
Signal score65
Mantra BioEst. 2016
AMAlex MokUnited States
Signal score64
InsilixaEst. 2011
Martin PieprzykUnited States
Signal score64
Precision NanoSystemEst. 2010
Carl HansenCanada
Signal score64
BioSkrybEst. 2018
JWJay WestZUnited States
Signal score62

Book a demo to explore the full alumni network →

Global footprint

Where Standard Biotools has talent and traffic

Workforce by country
20 countries with
team presence
🇺🇸 United States46%
🇨🇦 Canada27.9%
🇸🇬 Singapore8.9%
🇬🇧 United Kingdom4%
🇫🇷 France2.9%
Top 5 of 20 shown
Web traffic by country
19K monthly visits
across markets
🇺🇸 United States36.8%
🇨🇦 Canada11.1%
🇬🇧 United Kingdom9.5%
🇫🇷 France7.9%
🇯🇵 Japan7.9%
Top 5 markets shown

Patent intelligence

$68M patent portfolio · 62 active families

Estimated portfolio value
$68M
35.3× smaller than top peer Illumina ($2.4B)
62 active patent families
Where Standard Biotools innovates Mass Spectrometry-Mass SpectrometryMass analyzerMass cytometryMolecular biologyNucleic acid

Where Standard Biotools concentrates vs peers

Each axis is a top-10 topic across Standard Biotools and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Standard Biotools

An AI-synthesized read of the highest-engagement posts about Standard Biotools on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Standard Biotools on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles